Latest Diabetes: Type II news
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
posted May 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Midlife Onset of Increasing Pulse Pressure Not Linked to Menopause 
Intensive BP Lowering Reduces Recurrent Stroke After Intracerebral Hemorrhage 
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians 
Antenatal Complications Increased With Maternal Multiple Long-Term Conditions Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
